*This course has been retired. Please click here for new course: COVID NIH Treatment Guidelines.
Summary
National Institutes of Health
This section focuses on the COVID-19 Treatment Guidelines Panel’s (the Panel) recommendations for using small-molecule antiviral drugs to treat COVID-19.
Remdesivir remains the only drug that is approved by the Food and Drug Administration for the treatment of COVID-19. Ritonavir-boosted nirmatrelvir (Paxlovid), molnupiravir, and certain anti-SARS-CoV-2 monoclonal antibodies (mAbs) have received Emergency Use Authorizations from the FDA for the treatment of COVID-19.
This section also provides information about antiviral drugs that are not recommended for the treatment of COVID-19.
Instructions
- Click on the PDF link below to access this section.
- Return to this page. Click “Next” below access the next section.
- The last section provides a link to the quiz, registration, payment, and certificate.
